pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Trump administration issues new rules to standardize health-insurance pricing disclosures

Oct 5, 2026·read at STAT ↗RegulatoryNeutral

The Trump administration on Monday issued new regulations that require health-insurance companies to release cleaned-up spreadsheets showing the amounts they pay hospitals and physicians. The rules strip out extraneous data that previously cluttered the files.

The agencies also announced that work will begin next month on a system to disclose prescription-drug pricing. Mehmet Oz, the head of Medicare and Medicaid, said a tentative final plan for drug-price data is expected by May of next year.

The government will enforce the new reporting requirements by the end of 2027. Last year the administration delayed finalizing drug-price disclosure rules, a move that had been welcomed by drug makers and pharmacy-benefit managers.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: New Trump regulations would clean up health care pricing disclosures”

read at STAT ↗
528 words · retrieved 33m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LILLY2
drugs
pirtobrutinib
topics
CLL

related stories

  • 3h agoSTAT+: Prices, prices, pricesSTAT
  • 4h agoSTAT+: Utah plows ahead with more health AI pilots for prescriptions, women’s healthSTAT
  • 6h agoOptogenetics researchers win a Nobel Prize; Roche bets on Alector brain drugBioPharma Dive
  • 6h agoSTAT+: Lilly’s Jaypirca approved as first-line CLL therapySTAT
  • Jun 26On second try, Acadia drug gets nod from European regulatorsBioPharma Dive